What's in Naval Aeromedical Research Unit, Dayton's pipeline?

Naval Aeromedical Research Unit, Dayton has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Naval Aeromedical Research Unit, Dayton's portfolio?

Top competitors by shared drug class: AbbVie, Aclaris Therapeutics, Inc., Ain Shams University, Astellas Pharma Inc, Boehringer Ingelheim.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/naval-aeromedical-research-unit-dayton.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Naval Aeromedical Research Unit, Dayton — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Naval Aeromedical Research Unit, Dayton pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Scopolamine Transdermal Patch [Transderm Scop]	Scopolamine Transdermal Patch [Transderm Scop]	phase 3	Anticholinergic	Muscarinic acetylcholine receptors (M1-M5)	Motion Sickness, Postoperative Nausea and Vomiting

Therapeutic area mix

Motion Sickness, Postoperative Nausea and Vomiting · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie · 1 shared drug class
Aclaris Therapeutics, Inc. · 1 shared drug class
Ain Shams University · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
Boehringer Ingelheim · 1 shared drug class
Covis · 1 shared drug class
Forest Labs Inc · 1 shared drug class
· 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Naval Aeromedical Research Unit, Dayton:

Cite this brief

Drug Landscape (2026). Naval Aeromedical Research Unit, Dayton — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/naval-aeromedical-research-unit-dayton. Accessed 2026-05-17.